Harry Man Xiong Lai1, Michelle Cleary2, Thiagarajan Sitharthan3, Glenn E Hunt4. 1. Discipline of Psychiatry, University of Sydney, NSW, Australia. Electronic address: man-xiong.lai@sydney.edu.au. 2. School of Nursing and Midwifery, University of Western Sydney, NSW, Australia. Electronic address: m.cleary@uws.edu.au. 3. Discipline of Psychiatry, University of Sydney, NSW, Australia. Electronic address: Thiagarajan.Sitharthan@sydney.edu.au. 4. Discipline of Psychiatry, University of Sydney, NSW, Australia. Electronic address: glenn.hunt@sydney.edu.au.
Abstract
BACKGROUND: Comorbidity is highly prevalent between substance use disorders (SUDs), mood and anxiety disorders. We conducted a systematic review and meta-analysis to determine the strength of association between SUDs, mood and anxiety disorders in population-based epidemiological surveys. METHODS: A comprehensive literature search of Medline, EMBASE, CINAHL, PsychINFO, Web of Science, and Scopus was conducted from 1990 to 2014. Sources were chosen on the basis that they contained original research in non-clinical populations conducted in randomly selected adults living within defined boundaries. Prevalence of comorbid SUDs, mood and anxiety disorders and odds ratios (ORs) were extracted. RESULTS: There were 115 articles identified by electronic searches that were reviewed in full text which yielded 22 unique epidemiological surveys to extract lifetime and 12-month prevalence data for psychiatric illness in respondents with an SUD. Meta-analysis indicated the strongest associations were between illicit drug use disorder and major depression (pooled OR 3.80, 95% CI 3.02-4.78), followed by illicit drug use and any anxiety disorder (OR 2.91, 95% CI 2.58-3.28), alcohol use disorders and major depression (OR 2.42, 95% CI 2.22-2.64) and alcohol use disorders and any anxiety disorder (OR 2.11, 95% CI 2.03-2.19). ORs for dependence were higher than those for abuse irrespective to diagnoses based on lifetime or 12-month prevalence. CONCLUSIONS: This review confirms the strong association between SUDs, mood and anxiety disorders. The issue has now been recognised worldwide as a factor that affects the profile, course, patterns, severity and outcomes of these disorders.
BACKGROUND: Comorbidity is highly prevalent between substance use disorders (SUDs), mood and anxiety disorders. We conducted a systematic review and meta-analysis to determine the strength of association between SUDs, mood and anxiety disorders in population-based epidemiological surveys. METHODS: A comprehensive literature search of Medline, EMBASE, CINAHL, PsychINFO, Web of Science, and Scopus was conducted from 1990 to 2014. Sources were chosen on the basis that they contained original research in non-clinical populations conducted in randomly selected adults living within defined boundaries. Prevalence of comorbid SUDs, mood and anxiety disorders and odds ratios (ORs) were extracted. RESULTS: There were 115 articles identified by electronic searches that were reviewed in full text which yielded 22 unique epidemiological surveys to extract lifetime and 12-month prevalence data for psychiatric illness in respondents with an SUD. Meta-analysis indicated the strongest associations were between illicit drug use disorder and major depression (pooled OR 3.80, 95% CI 3.02-4.78), followed by illicit drug use and any anxiety disorder (OR 2.91, 95% CI 2.58-3.28), alcohol use disorders and major depression (OR 2.42, 95% CI 2.22-2.64) and alcohol use disorders and any anxiety disorder (OR 2.11, 95% CI 2.03-2.19). ORs for dependence were higher than those for abuse irrespective to diagnoses based on lifetime or 12-month prevalence. CONCLUSIONS: This review confirms the strong association between SUDs, mood and anxiety disorders. The issue has now been recognised worldwide as a factor that affects the profile, course, patterns, severity and outcomes of these disorders.
Authors: M Bauer; T Banaschewski; A Heinz; I Kamp-Becker; A Meyer-Lindenberg; F Padberg; M A Rapp; R Rupprecht; F Schneider; T G Schulze; H-U Wittchen Journal: Nervenarzt Date: 2016-09 Impact factor: 1.214
Authors: Breanne Hobden; Melanie L Schwandt; Mariko Carey; Mary R Lee; Mehdi Farokhnia; Sofia Bouhlal; Christopher Oldmeadow; Lorenzo Leggio Journal: Alcohol Clin Exp Res Date: 2017-05-22 Impact factor: 3.455
Authors: Noa Krawczyk; Kenneth A Feder; Brendan Saloner; Rosa M Crum; Marc Kealhofer; Ramin Mojtabai Journal: Drug Alcohol Depend Date: 2017-04-19 Impact factor: 4.492
Authors: Jennifer C Wolff; Sarah A Thomas; Erik Hood; Alexandra H Bettis; Christie J Rizzo; Richard T Liu Journal: J Affect Disord Date: 2020-09-02 Impact factor: 4.839